Symptoms | Present case | Hellyanti et al., 2021 [7] | Yoshimatsu et al., 2020 [8] | Haroon et al., 2015 [4] | Yılmaz-Ağladıoğlu et al., 2013 [13] | Boyraz et al., 2013 [14] | Lee et al., 2011 [6] | Sawathiparnich et al., 2009 [11] | Gupta et al., 2008 [10] | Ding and Hsu., 2007 [15] | Lin et al., 2000 [5] | Harris et al., 1991 [12] | Total case (N = 12) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Isosexual precocity | + | Â | Â | + | Â | Â | + | Â | Â | Â | + | Â | 4/12 (33%) |
Heterosexual precocity | Â | + | + | Â | + | + | Â | + | + | + | Â | + | 8/12 (66%) |
Breast Development | + | Â | Â | + | Â | Â | + | Â | Â | Â | + | Â | 4/12 (33%) |
Pubic hair growth | + | + | Â | Â | Â | Â | + | Â | Â | Â | + | Â | 4/12 (33%) |
Vaginal bleeding | Â | Â | Â | + | Â | Â | + | Â | Â | Â | + | Â | 3/12 (25%) |
Nipples pigmentation | + | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | 1/12 (8%) |
Virilization | Â | + | + | Â | + | + | Â | Â | Â | + | Â | + | 6/12 (50%) |
Amenorrhea | Â | Â | Â | Â | Â | + | Â | Â | Â | + | Â | Â | 2/12 (17%) |
Hirsutism | Â | + | Â | Â | Â | Â | Â | Â | + | + | Â | Â | 3/12 (25%) |
Facial acnes | Â | + | Â | Â | Â | Â | Â | Â | + | Â | Â | Â | 2/12 (17%) |
Hypertrichosis | Â | + | Â | Â | Â | Â | Â | Â | + | Â | Â | Â | 2/12 (17%) |
Temporal balding | Â | Â | Â | Â | Â | Â | Â | Â | Â | + | Â | Â | 1/12 (8%) |
Cushing’s syndrome |  | + | + |  |  |  |  | + | + |  |  |  | 4/12 (33%) |
Hypertension | Â | + | Â | Â | Â | Â | + | Â | Â | Â | Â | Â | 2/12 (17%) |